---
document_datetime: 2024-10-25 12:06:43
document_pages: 12
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/hulio-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: hulio-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 7.1564916
conversion_datetime: 2025-12-28 03:04:17.609815
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Hulio

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                                                                                                                                        | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| IB/0046              | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH | 18/10/2024                          |                                             | SmPC                             |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| IAIN/0045           | B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing              | 30/11/2023   |            | Annex II and PL        |                                                                                                                                                                                                                                                                     |
|---------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| PSUSA/10783 /202212 | Periodic Safety Update EU Single assessment - adalimumab                                                                                                                                                                                            | 31/08/2023   | n/a        |                        | PRAC Recommendation - maintenance                                                                                                                                                                                                                                   |
| T/0044              | Transfer of Marketing Authorisation                                                                                                                                                                                                                 | 03/08/2023   | 30/08/2023 | SmPC, Labelling and PL |                                                                                                                                                                                                                                                                     |
| R/0041              | Renewal of the marketing authorisation.                                                                                                                                                                                                             | 25/05/2023   | 03/08/2023 | SmPC and PL            | Based on the review of data on quality, safety and efficacy, the CHMP considered that the benefit-risk balance of Hulio in the approved indication remains favourable and therefore recommended the renewal of the marketing authorisation with unlimited validity. |
| IAIN/0043           | B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site                                                                                                                                                  | 24/05/2023   | n/a        |                        |                                                                                                                                                                                                                                                                     |
| IB/0039             | B.II.f.1.b.z - Stability of FP - Extension of the shelf life of the finished product - Other variation                                                                                                                                              | 05/12/2022   | 03/08/2023 | SmPC and PL            |                                                                                                                                                                                                                                                                     |
| IA/0040/G           | This was an application for a group of variations. A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excluding manufacturer for batch release) | 30/11/2022   | n/a        |                        |                                                                                                                                                                                                                                                                     |

<div style=\"page-break-after: always\"></div>

|           | - Administrative change - Deletion of sites                                                                                                                                                                                                                                                                                       |            |            |             | A.7 manufacturing   |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------|---------------------|
| IB/0038   | B.II.f.1.b.1 - Stability of FP - Extension of the shelf life of the finished product - As packaged for sale (supported by real time data)                                                                                                                                                                                         | 22/09/2022 | 03/08/2023 | SmPC and PL |                     |
| IB/0037   | C.I.11.z - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation, including the RMP - Other variation                                                                                                                                                                                     | 13/07/2022 | n/a        |             |                     |
| IB/0036   | B.II.z - Quality change - Finished product - Other                                                                                                                                                                                                                                                                                | 29/06/2022 | n/a        |             | variation           |
|           | This was an application for a group of variations. B.II.e.7.a - Change in supplier of packaging components or devices (when mentioned in the dossier) - Deletion of a supplier B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure                                       | 24/03/2022 | n/a        |             | IA/0035/G           |
| IB/0034/G | This was an application for a group of variations. B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place B.II.b.2.z - Change to importer, batch release arrangements and quality control testing of the FP - | 28/02/2022 | n/a        |             | Other variation     |

<div style=\"page-break-after: always\"></div>

| T/0033      | Transfer of Marketing Authorisation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | 18/10/2021   | 15/11/2021   | SmPC, Labelling and PL   |
|-------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|--------------------------|
| IAIN/0032/G | This was an application for a group of variations. B.IV.1.b - Change of a measuring or administration device - Deletion of a device B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes B.IV.1.b - Change of a measuring or administration device - Deletion of a device B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within | 29/09/2021   | 15/11/2021   | SmPC, Labelling and PL   |

<div style=\"page-break-after: always\"></div>

|         | - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within   |            |            |             | product   |
|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------|-----------|
| IB/0031 | B.II.f.1.b.5 - Stability of FP - Extension of the shelf life of the finished product - Biological/immunological medicinal product in accordance with an approved stability protocol                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | 27/08/2021 | 15/11/2021 | SmPC and PL |           |
| IB/0030 | B.I.z - Quality change - Active substance - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | 09/08/2021 | n/a        |             |           |
| IB/0029 | B.II.d.1.z - Change in the specification parameters and/or limits of the finished product - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | 09/07/2021 | n/a        |             |           |

<div style=\"page-break-after: always\"></div>

| IB/0028/G   | This was an application for a group of variations. B.II.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change in the manufacturing process B.II.b.5.z - Change to in-process tests or limits applied during the manufacture of the finished                                                                                                                       | 16/06/2021   | n/a        |                        | product - Other variation   |
|-------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|------------------------|-----------------------------|
| IB/0027     | B.II.f.1.b.5 - Stability of FP - Extension of the shelf life of the finished product - Biological/immunological medicinal product in accordance with an approved stability protocol                                                                                                                                                                                                                            | 15/06/2021   | 15/11/2021 | SmPC                   |                             |
| IB/0026/G   | This was an application for a group of variations. C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH | 03/05/2021   | 04/06/2021 | SmPC, Labelling and PL |                             |
| IA/0025     | A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                                                                                                                                                                                                                                                  | 02/03/2021   | 04/06/2021 | Annex II and PL        |                             |
| X/0016      | Annex I_2.(c) Change or addition of a new strength/potency                                                                                                                                                                                                                                                                                                                                                     | 15/10/2020   | 14/12/2020 | SmPC, Labelling and PL |                             |

<div style=\"page-break-after: always\"></div>

| II/0021             | B.II.d.1.e - Change in the specification parameters and/or limits of the finished product - Change outside the approved specifications limits range                                                                                                                                                                                                                     | 10/12/2020   | n/a        |             |                                   |
|---------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|-------------|-----------------------------------|
| IB/0024             | B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS                                                                                                                                                                                                                                                        | 08/12/2020   | n/a        |             |                                   |
| IB/0023/G           | This was an application for a group of variations. B.II.b.2.z - Change to importer, batch release arrangements and quality control testing of the FP - Other variation A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excluding manufacturer for batch release) | 11/11/2020   | n/a        |             |                                   |
| IAIN/0022           | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                                                                          | 09/10/2020   | 14/12/2020 | SmPC and PL |                                   |
| PSUSA/10783 /201912 | Periodic Safety Update EU Single assessment - adalimumab                                                                                                                                                                                                                                                                                                                | 03/09/2020   | n/a        |             | PRAC Recommendation - maintenance |
| IB/0019/G           | This was an application for a group of variations. B.I.e.5.c - Implementation of changes foreseen in an approved change management protocol - For a biological/immunological medicinal product B.II.g.5.c - Implementation of changes foreseen in an approved change management protocol - For a biological/immunological medicinal product                             | 23/07/2020   | n/a        |             |                                   |

<div style=\"page-break-after: always\"></div>

| IAIN/0020   | B.IV.1.a.1 - Change of a measuring or administration device - Addition or replacement of a device which is not an integrated part of the primary packaging - Device with CE marking                                                                                                                                                                                                                            | 15/07/2020   | n/a        |                        |             |
|-------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|------------------------|-------------|
| IAIN/0018/G | This was an application for a group of variations. B.IV.1.a.1 - Change of a measuring or administration device - Addition or replacement of a device which is not an integrated part of the primary packaging - Device with CE marking B.IV.1.a.1 - Change of a measuring or administration device - Addition or replacement of a device which is not an integrated part of the primary packaging - CE marking | 10/04/2020   | n/a        |                        | Device with |
| IB/0015     | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                                                                                                                                   | 05/02/2020   | 14/12/2020 | SmPC, Labelling and PL |             |
| IB/0014/G   | This was an application for a group of variations. B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate - Change in test procedure for the finished                                                                                                    | 20/12/2019   | n/a        |                        | B.II.d.2.d  |

<div style=\"page-break-after: always\"></div>

|             | - Other changes to a test procedure replacement or addition)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |            |            |                 | product (including   |
|-------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-----------------|----------------------|
| IB/0012/G   | This was an application for a group of variations. B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place B.II.b.2.z - Change to importer, batch release arrangements and quality control testing of the FP -                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | 08/11/2019 | n/a        |                 | Other variation      |
| IAIN/0013/G | This was an application for a group of variations. A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excluding manufacturer for batch release) B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging | 18/10/2019 | 19/11/2019 | Annex II and PL |                      |

<div style=\"page-break-after: always\"></div>

|                     | site B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing                                                    |            |            |                 |                                   |
|---------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-----------------|-----------------------------------|
| II/0010/G           | This was an application for a group of variations. B.I.e.2 - Introduction of a post approval change management protocol related to the AS B.II.g.2 - Introduction of a post approval change management protocol related to the finished product                                                | 12/09/2019 | n/a        |                 |                                   |
| IB/0011             | B.I.a.1.z - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Other variation                                                                                                                                                                           | 13/08/2019 | 19/11/2019 | Annex II and PL |                                   |
| PSUSA/10589 /201812 | Periodic Safety Update EU Single assessment - adalimumab (biosimilars)                                                                                                                                                                                                                         | 11/07/2019 | n/a        |                 | PRAC Recommendation - maintenance |
| II/0009             | C.I.11.b - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation, including the RMP - Implementation of change(s) which require to be further substantiated by new additional data to be submitted by the MAH where significant assessment is required | 14/06/2019 | n/a        |                 |                                   |
| II/0004             | C.I.13 - Other variations not specifically covered elsewhere in this Annex which involve the submission of studies to the competent authority                                                                                                                                                  | 11/04/2019 | n/a        |                 |                                   |

<div style=\"page-break-after: always\"></div>

| IB/0007     | - Introduction of, or change(s) to, the and conditions of a marketing including the RMP - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                        | 10/04/2019   | 19/11/2019   | SmPC, Annex II and PL   | C.I.11.z obligations authorisation,   |
|-------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|-------------------------|---------------------------------------|
| II/0001     | B.II.b.2.b - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place for a biol/immunol product and any of the test methods at the site is a biol/immunol method                                                                                                                                                                                                                                                           | 17/01/2019   | n/a          |                         |                                       |
| IB/0005     | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                                                                                                                                                                                                                                                     | 09/01/2019   | 19/11/2019   | SmPC, Labelling and PL  |                                       |
| IAIN/0006/G | This was an application for a group of variations. B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing | 19/12/2018   | 19/11/2019   | Annex II and PL         |                                       |

<div style=\"page-break-after: always\"></div>

| IB/0003   | B.II.e.5.a.2 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change outside the range of the currently approved pack sizes   | 14/12/2018   | 19/11/2019   | SmPC, Labelling and PL   |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|--------------------------|
| IB/0002   | B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place                            | 07/11/2018   | n/a          |                          |